Yahoo Web Search

  1. Yahoo Finance Results

  2. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices ...

  3. Merck (MRK) Receives Approval for 2 HIV Medicines in EU

    Zacks via Yahoo FinanceNov 29 21:21 PM

    Merck & Co., Inc. MRK announced that the European Commission has approved two new HIV drugs — Pifeltro and Delstrigo — containing, doravirine, a non-nucleoside reverse transcriptase ...

    78.01+0.90 (+1.17%)

    at Wed, Dec 12, 2018, 16:01PM EST - U.S. Markets open in 7 hrs 31 mins

    After Hours 78.13 +0.12 (+0.15%)

    Delayed Quote

    • Open 77.77
    • High 78.76
    • Low 77.72
    • 52 Wk. High 80.19
    • 52 Wk. Low 52.83
    • Mkt. Cap 202.86B
  4. 4 Big Pharma Stocks to Add to Your Portfolio in December

    Zacks via Yahoo FinanceNov 29 13:10 PM

    Large –Cap Pharma and Biomed/Genetics Versus S&P 500 The Large-Cap Pharmaceuticals industry features among the top 30% of the 255 Zacks-ranked industries We believe that strong quarterly results ...

  5. Emergent Biosolutions Inc (NYSE: EBS) Vericel Corp (NASDAQ: VCEL) Aduro BioTech Inc (NASDAQ: ADRO) Aerpio Pharmaceuticals Inc (NASDAQ: ARPO) Corvus Pharmaceuticals Inc ...

  6. Of the nine potential legislative catalysts ahead in the next month, Harris said she expects two of them to pass: measures that would financially impact Roche Holdings AG Basel ADR Common Stock ...

  7. NYSE: MRK) Ionis Pharmaceuticals Inc (NASDAQ: IONS) Avanos Medical Inc (NYSE: AVNS) Aptevo Therapeutics Inc (NASDAQ: APVO) Aquestive Therapeutics Inc (NASDAQ: AQST ...

  8. Glaxo Inks Marketing Deal for Anaemia Candidate in Japan

    Zacks via Yahoo FinanceNov 26 14:33 PM

    GlaxoSmithKline plc GSK announced that it has signed a strategic collaboration deal with Japanese company Kyowa Hakko Kirin Co., Ltd for the future commercialization of its late-stage ...

  9. Merck raised prices five drugs including Keytruda in November

    Reuters via Yahoo FinanceNov 28 23:36 PM

    Merck & Co Inc said on Wednesday it raised U.S. prices on five of its drugs earlier in November by between 1.5 percent and 6 percent, including its top-selling cancer treatment ...

  10. Investors in Merck & Co., Inc. MRK need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 7, 2018 $71.00 Call had ...

  11. NYSE: PFE) Aimmune Therapeutics Inc (NASDAQ: AIMT)(announced closing of $98 million equity investment by Nestlé Health Science) BioXcel Therapeutics Inc (NASDAQ: BTAI) CELLECT ...